Evaluation of the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a Probe
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
Open label evaluation of potential interaction of F901318 with cytochrome P450 3A4 using
midazolam as a probe. Twenty healthy male subjects will participate